|
|
201 E. Jefferson, Suite 315 Louisville, KY 40202 USA phone:(502) 569-1020 fax:(502) 569-1021
|
|
| Symbol |
Private |
| Founded |
2005 |
| Employees |
|
|
|
| www.rhinocyte.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Stem-cell-based diagnostic tools and therapies for the treatment of degenerative neurological diseases such as Parkinson's and Multiple Sclerosis |
 |
| Management |
| Fred Roisen, Founder, President and CEO; Teresa Leezer, VP Business Strategy |
| |
|
|
| |
|
| Keywords |
| neurology, stl, ALS, parkinsons, multiple sclerosis, spinal cord injury, christopher reeve, stem cells, neurodegenerative |
|
|
|
|
|
|
| Description |
|
RhinoCyte Inc. is a biotechnology company commercializing autologous adult olfactory-derived stem cell therapies to treat spinal cord injury and neurodegenerative disorders such as Amyotrophic Lateral Sclerosis, Parkinson's disease, and Multiple Sclerosis. |
 |
| Products / Services |
|
According to a standardized procedure the olfactory tissue would be harvested endoscopically by an ENT physician at the patient's site. The tissue will then be shipped to RhinoCyte's Louisville labor...
view more
|
 |
| Technology / Differentiation |
| The core technology involves the biopsy, harvesting, isolation, processing, cryo-preservation and engraftment of adult progenitors into the site of injury. RhinoCyte's lead therapeutic candidate is an autologous cellular enhancement therapy which provides a biologically active bridge that promotes recovery of spinal cord injury induced neural damage. |
 |
| Market / Customers |
|
Spinal cord injury affects more than 250,000 patients in the US alone, with 13,000 new cases annually. According to the National Spinal Cord Injury Statistical Center, annual total costs for spinal co...
view more
|
 |
| Status |
| The company currently seeks Series B funding to develop and commercialize its lead product for spinal cord injuries, specifically to submit an IND and commence phase I trials in 2010. |
 |
|
|
|
|
|
|